Tag: Ziyad Al-Aly March 18, 2026 Stopping GLP-1s raises risk of heart attack, stroke and death, study saysSource: CNBC March 18, 2026 Stopping GLP-1 drugs can quickly erase cardiovascular benefitsEven brief interruption tied to change in risk of heart attack, stroke and death.News Release March 4, 2026 GLP-1 medications get at the heart of addiction: studyDiabetes and obesity drugs show promise in treating and preventing all substance use disorders.News Release March 4, 2026 Weight-Loss Drugs Could Prevent and Treat Addiction, New Research ShowsSource: Time Magazine March 4, 2026 Flu was again worse than covid this winter. Is that pattern here to stay?Source: The Washington Post July 10, 2025 What long covid can teach us about future pandemicsSource: The Washington Post January 28, 2025 Obesity Drug Study Points to Effectiveness in Curbing AddictionsSource: Bloomberg September 23, 2024 What Repeat COVID Infections Do to Your Body, According to ScienceIn the News July 17, 2024 Risk of long COVID declined over course of pandemicDrop attributed mostly to vaccination but remaining risk still significant.News Release May 30, 2024 Risk of death from COVID-19 lessens, but infection still can cause issues 3 years laterStudy also shows that patients hospitalized within 30 days after infection face 29% higher death risk in 3rd year compared with those not infected.News Release May 2, 2024 Al-Aly on TIME100 Health list of people who have most influenced global healthRecognized for influential research on long COVID.National Leaders December 14, 2023 ‘Long flu’ has emerged as a consequence similar to long COVIDStudy shows patients hospitalized for flu or COVID-19 face increased risk of long-term health problems, death.News Release Posts navigation 1 2 3 4 Next ›